Project Grant HT94252510915
- This $1,847,457.00 Project Grant award, funded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports advanced biomedical research conducted by Vanderbilt University Medical Center (VUMC) in Nashville, Tennessee. The research aims to transform healthcare for military service members, veterans, and the broader public through innovative and impactful studies across various medical domains, including cancer, neuroscience, infectious...
- This $1,211,469 Project Grant, awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports a therapeutic intervention research project to reverse gastric precancer conducted by Vanderbilt University Medical Center (VUMC). The award, with a performance period from June 1, 2024 to May 31, 2028, will enable VUMC to leverage its clinical expertise and research capabilities to advance medical knowledge and improve patient care. As a leading...
- The U.S. Department of Defense's Defense Health Agency awarded a $1,317,028 Project Grant to Vanderbilt University Medical Center (VUMC) with a period of performance from June 1, 2024 to May 31, 2028. The grant, under CFDA 12.420 - Military Medical Research and Development program, will support VUMC's research into therapeutic interventions to reverse gastric precancer. As a leading academic medical center and biomedical research institution, VUMC will leverage its clinical expertise and...
- The Project Grant award of $621,943.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) is supporting research by Functional Circulation LLC, a for-profit company based in Lake Mills, Wisconsin. The award aims to investigate the DPEP1-neutrophil axis in microsatellite stable colorectal cancer, with a performance period from September 30, 2025 to September 29, 2028. This research project is part of the Defense Health Agency's broader efforts to...
- This federal Project Grant award of $1,267,303.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) to Vanderbilt University Medical Center (VUMC) supports research to define chronic immune-related adverse events in melanoma survivors. The funding period extends from August 1, 2025 to July 31, 2028. As a prominent academic medical center and federal contractor, VUMC has demonstrated extensive capabilities in providing specialized medical research...
- The U.S. Defense Health Agency awarded a $1,213,276 Project Grant to Yale University under the Military Medical Research and Development program (CFDA 12.420). This 3-year grant, effective September 1, 2023 through August 31, 2026, will fund research on the role of vascular mimicry in the outgrowth of dormant melanoma micrometastases. The goal of this research is to transform health care for Service Members and the American public through innovative and impactful medical research on solutions...
- The U.S. Defense Health Agency awarded a $241,500 Project Grant to Duke University under the Military Medical Research and Development program (CFDA 12.420) to conduct research on "UNDERSTANDING THE MOLECULAR COMMUNICATION BETWEEN PROSTATE CANCER CELL TYPES." The two-year grant, with a performance period from September 1, 2025 to August 31, 2027, will support advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public....
- The Defense Health Agency has awarded a $1,674,999.00 Project Grant to Yale University under the Military Medical Research and Development program (CFDA 12.420). The grant is for the "PERTURBOMICS IDENTIFICATION OF CRITICAL GENETIC TARGETS IN NK CELLS FOR BREAST CANCER THERAPY" project, which will be conducted from September 1, 2023 to August 31, 2026. The funding will support basic, applied, and advanced biomedical research to transform healthcare for service members and the public...
- This Project Grant award, totaling $2,399,874.00, was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to Vanderbilt University Medical Center (VUMC) for a project titled "Decoding the Inflammatory Spark and Fire: Unraveling the Molecular Basis of Post-Injury Syndrome and Mineralization Disorders". The award supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and...
- This $1,599,997.00 Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports advanced biomedical research at the University of Illinois aimed at transforming healthcare for military service members, veterans, and the broader public. The research, spanning basic, applied, and translational investigations, focuses on innovative approaches to address critical health challenges across diverse medical domains such as cancer,...
This $700,000 Project Grant, awarded on August 15, 2025 by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports research conducted by Vanderbilt University Medical Center (VUMC) to target the DPEP1-neutrophil axis in microsatellite stable colorectal cancer. The funding will enable VUMC, a prominent academic medical center, to advance biomedical research focused on developing innovative medical solutions to address critical health challenges relevant to military personnel and the broader public. This grant is part of the Defense Health Agency's broader portfolio of basic, applied, and translational research initiatives across various medical domains, including cancer, neuroscience, infectious diseases, and injury prevention.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $700.0k | 7/30/25 |